Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Kaletra”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT04466241
What this trial is testing

Combination Therapies to Reduce Carriage of SARS-Cov-2 and Improve Outcome of COVID-19 in Ivory Coast: a Phase Randomized IIb Trial

Who this might be right for
COVID-19COVID-19 Drug TreatmentSevere Acute Respiratory Syndrome Coronavirus 2
ANRS, Emerging Infectious Diseases 294
Post-approval studies (Phase 4)Ended earlyNCT01700790
What this trial is testing

Pharmacokinetic Study of Super-boosted Lopinavir/Ritonavir Given With Rifampin

Who this might be right for
AIDSTuberculosis
University of Miami 9
Large-scale testing (Phase 3)Study completedNCT00050895
What this trial is testing

Comparing the Safety, Effectiveness, and Tolerability of Three Anti-HIV Drug Regimens for Treatment-Naive Patients

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 775
Testing effectiveness (Phase 2)Study completedNCT00038532
What this trial is testing

Amprenavir/Ritonavir, Saquinavir/Ritonavir or Efavirenz in HIV-Infected Subjects Following Failure With Kaletra (ABT-378/Ritonavir) as Their First Protease Inhibitor Based HAART

Who this might be right for
HIV Infections
Abbott 24
Not applicableStudy completedNCT01076985
What this trial is testing

Special Investigation of Kaletra in Pregnant Women

Who this might be right for
Human Immunodeficiency Virus
Abbott 24
Early research (Phase 1)Study completedNCT00723775
What this trial is testing

GSK706769/KALETRA Drug-drug Interaction Study

Who this might be right for
Infection, Human Immunodeficiency Virus
GlaxoSmithKline 17
Not applicableStudy completedNCT01379703
What this trial is testing

Multicountry, Multicenter Post-Marketing Observational Study of Clinical, Biological and Virological Outcomes, Compliance and Tolerability of Kaletra® in Routine Clinical Use

Who this might be right for
HIV-1 Patients
Abbott 2,288
Large-scale testing (Phase 3)Study completedNCT00234923
What this trial is testing

Efficacy and Safety of Kaletra Monotheraphy Compared to Kaletra Based Triple Therapy to Treat HIV in Antiretroviral Naїve Patients

Who this might be right for
HIV Infection
Abbott 138
Large-scale testing (Phase 3)Study completedNCT00105079
What this trial is testing

GEMINI Study - A Study of Saquinavir/Ritonavir in Treatment-Naive Patients With HIV-1 Infection

Who this might be right for
HIV Infections
Hoffmann-La Roche 337
Early research (Phase 1)Study completedNCT01671982
What this trial is testing

ALternative TEnofovir Dosing in Adults With Moderate Renal Function Impairment

Who this might be right for
HIV
Institut de Recherche pour le Developpement 40
Post-approval studies (Phase 4)UnknownNCT04255017
What this trial is testing

A Prospective/Retrospective,Randomized Controlled Clinical Study of Antiviral Therapy in the 2019-nCoV Pneumonia

Who this might be right for
2019-nCoV
Tongji Hospital 400
Large-scale testing (Phase 3)Study completedNCT00086359
What this trial is testing

Comparison of Anti-HIV Drug Combinations to Prevent Mother-to-Child Transmission of HIV

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 19
Testing effectiveness (Phase 2)Study completedNCT01139905
What this trial is testing

Lopinavir/Ritonavir (LPV/r) Tablet in HIV Infected Children

Who this might be right for
HIV-1 Infections
The HIV Netherlands Australia Thailand Research Collaboration 24
Post-approval studies (Phase 4)Study completedNCT00772902
What this trial is testing

ROCKET II - Randomized Open Label Switch for Cholesterol Elevation on Kivexa + Kaletra Evaluation Trial

Who this might be right for
HIV-1
Gilead Sciences 85
Testing effectiveness (Phase 2)Study completedNCT01138202
What this trial is testing

Pharmacokinetics (PK) and Safety of 2 Different Doses of Lopinavir/Ritonavir in in HIV/Tuberculosis (TB) Co-infected Patients Receiving Rifampicin Containing Anti-tuberculosis Therapy

Who this might be right for
HIV InfectionsTuberculosis
The HIV Netherlands Australia Thailand Research Collaboration 40
Post-approval studies (Phase 4)Study completedNCT00139178
What this trial is testing

Switching From Zidovudine to an NNRTI or Lopinavir/Ritonavir in Patients Treated With Zidovudine/ Lamivudine/Abacavir.

Who this might be right for
HIV Associated Lipodystrophy Syndrome.HIVHypercholesterolemia+1 more
Danish HIV Research Group 100
Post-approval studies (Phase 4)Study completedNCT00281606
What this trial is testing

Study to Assess the Tolerability of Once Daily Lopinavir/Ritonavir (LPV/r) Liquid Versus Capsules

Who this might be right for
HIV Infection
University of California, San Diego 65
Testing effectiveness (Phase 2)Study completedNCT00084058
What this trial is testing

Safety of Saquinavir and High Doses of Lopinavir/Ritonavir in Children With HIV

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 26
Large-scale testing (Phase 3)Study completedNCT00085943
What this trial is testing

KALETRA Or LEXIVA With Ritonavir Combined With EPIVIR And Abacavir In Naive Subjects Over 48 Weeks

Who this might be right for
HIV InfectionInfection, Human Immunodeficiency Virus
GlaxoSmithKline 866
Post-approval studies (Phase 4)Study completedNCT00619944
What this trial is testing

Drug Interaction Study Between Lumefantrine and Lopinavir/Ritonavir

Who this might be right for
HIV Infections
Makerere University 32
Next Page